![Nicky P 🏃🏻♀️😻🚑🏴 on X: "Post for awareness; I ended up in ED last week due to blood loss. Thankfully not enough for transfusion but need further treatment & diagnostics. Now have Nicky P 🏃🏻♀️😻🚑🏴 on X: "Post for awareness; I ended up in ED last week due to blood loss. Thankfully not enough for transfusion but need further treatment & diagnostics. Now have](https://pbs.twimg.com/media/EgOvAciXsAARD0f.jpg:large)
Nicky P 🏃🏻♀️😻🚑🏴 on X: "Post for awareness; I ended up in ED last week due to blood loss. Thankfully not enough for transfusion but need further treatment & diagnostics. Now have
![UChicagoIBD on X: "RT @ibdmd: A sneak peek at the new budesonide rectal foam, coming soon. Easy to use & good for pts. @UChicagoIBD http://t.co/Kh35IO4rFI" / X UChicagoIBD on X: "RT @ibdmd: A sneak peek at the new budesonide rectal foam, coming soon. Easy to use & good for pts. @UChicagoIBD http://t.co/Kh35IO4rFI" / X](https://pbs.twimg.com/media/B8JLSNrIIAAV1Z2.jpg:large)
UChicagoIBD on X: "RT @ibdmd: A sneak peek at the new budesonide rectal foam, coming soon. Easy to use & good for pts. @UChicagoIBD http://t.co/Kh35IO4rFI" / X
![Marketing Approval for Ulcerative Colitis Treatment "RECTABUL® 2 mg Rectal Foam 14 Doses" was Obtained in Japan | News Release(2017) | English Home | KISSEI PHARMACEUTICAL CO.,LTD. Marketing Approval for Ulcerative Colitis Treatment "RECTABUL® 2 mg Rectal Foam 14 Doses" was Obtained in Japan | News Release(2017) | English Home | KISSEI PHARMACEUTICAL CO.,LTD.](https://www.kissei.co.jp/e_contents/news/uploaded/5be66f1ecdf8fd557b30839deb43eb07_1.jpg)